FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer

THURSDAY, Feb. 15, 2024 -- The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) plus oxaliplatin, fluorouracil, and leucovorin (NALIRIFOX) as a first-line treatment for adults living with metastatic pancreatic...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news